scholarly journals Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer

2018 ◽  
Vol 13 (8) ◽  
pp. 1156-1170 ◽  
Author(s):  
Louis Fehrenbacher ◽  
Joachim von Pawel ◽  
Keunchil Park ◽  
Achim Rittmeyer ◽  
David R. Gandara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Efficacy Analysis ◽  
Phase Iii Study ◽  
Previously Treated ◽  
Secondary Population

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen

Pneumologie ◽  
2008 ◽  
Vol 62 (S 2) ◽  
Author(s):  
J von Pawel ◽  
M Reck ◽  
R Ramlau ◽  
J Jassem ◽  
P Zatloukal ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Previously Treated

scholarly journals Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

2018 ◽  
Vol 29 (7) ◽  
pp. 1548-1553 ◽  
Author(s):  
D.E. Gerber ◽  
L. Horn ◽  
M. Boyer ◽  
R. Sanborn ◽  
R. Natale ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Previously Treated

A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 8009-8009 ◽  
Author(s):  
David R. Spigel ◽  
Karen L. Reckamp ◽  
Naiyer A. Rizvi ◽  
Elena Poddubskaya ◽  
Howard Jack West ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Programmed Death ◽  
Phase Iii Study ◽  
Programmed Death 1 ◽  
Previously Treated

PL-5 A phase III study of pemetrexed vs. docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) who were previously treated with chemotherapy

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S4 ◽  
Author(s):  
Frances A. Shepherd ◽  
Jose R. Pereira ◽  
Joachim Von Pawel ◽  
Ulrich Gatzemeier ◽  
Thomas Chang Yao Tsao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Previously Treated

scholarly journals A3-05: Phase III study of vinflunine versus docetaxel in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) previously treated with a platinum containing regimen

2007 ◽  
Vol 2 (8) ◽  
pp. S317-S318 ◽  
Author(s):  
Rodryg Ramlau ◽  
Jaafar Bennouna ◽  
Eng Huat Tan ◽  
Bonne Biesma ◽  
Armando Santoro ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Previously Treated

scholarly journals OA03.05 Phase III Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

2021 ◽  
Vol 16 (3) ◽  
pp. S107-S108
Author(s):  
A. Nakamura ◽  
Y. Yoneshima ◽  
S. Morita ◽  
M. Ando ◽  
S. Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Previously Treated

57 Pemetrexed vs docetaxel: a phase III study in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy

2003 ◽  
Vol 1 (5) ◽  
pp. S22 ◽  
Author(s):  
C. Manegold ◽  
R. Gervais ◽  
K. Aigner ◽  
C. Desch ◽  
H. Lim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Phase Iii Study ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document